BMRA logo



BMRA: Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.


Show BMRA Financials

Consumer Interest
SEC Filings

Recent trades of BMRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BMRA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Ibs sensitivity testing Sep. 29, 2020
  • Patent Title: Compositions, devices, and methods of ibs sensitivity testing Jun. 04, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BMRA in WallStreetBets Daily Discussion


Recent insights relating to BMRA

CNBC Recommendations

Recent picks made for BMRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BMRA

Corporate Flights

Flights by private jets registered to BMRA